Suppr超能文献

采用毛细管电泳技术快速高分辨率表征具有重要功能的单克隆抗体 N-糖基化。

Rapid high-resolution characterization of functionally important monoclonal antibody N-glycans by capillary electrophoresis.

机构信息

Barnett Institute, Northeastern University, Boston, Massachusetts 02115, USA.

出版信息

Anal Chem. 2011 Jul 1;83(13):5329-36. doi: 10.1021/ac2007587. Epub 2011 Jun 2.

Abstract

Characterization of the N-glycosylation present in the Fc region of therapeutic monoclonal antibodies requires rapid, high-resolution separation methods to guarantee product safety and efficacy during all stages of process development. Determination of fucosylated oligosaccharides is particularly important during clone selection, product characterization, and lot release as fucose has been shown to adversely affect the ability of mAbs to induce antibody dependent cellular cytotoxicity (ADCC). Here, we apply a general capillary electrophoresis optimization strategy to separate functionally relevant fucosylated and afucosylated glycans on mononclonal antibody products in the presence of several high mannose oligosaccharides. The N-glycans chosen represent those most commonly reported on CHO cell derived therapeutic antibodies. A rapid (<7 min) high-resolution separation of 12 commonly reported and functionally important IgG glycans was developed by systematically evaluating the effects of selectivity (boric acid) and efficiency (linear polyacrylamide) enhancing additives. The approach can be used to rapidly optimize capillary electrophoresis separation of other glycan mixtures. Following optimization, the method was applied to overnight sample processing for automated 96 well plate-based glycosylation analyses of two nonproprietary therapeutic monoclonal antibodies, demonstrating ruggedness and suitability for high-throughput process and product monitoring applications.

摘要

鉴定治疗性单克隆抗体 Fc 区域中的 N-糖基化需要快速、高分辨率的分离方法,以保证在工艺开发的所有阶段产品的安全性和功效。在克隆选择、产品表征和批次放行期间,确定岩藻糖基化的寡糖尤为重要,因为岩藻糖已被证明会影响单克隆抗体诱导抗体依赖性细胞毒性 (ADCC) 的能力。在这里,我们应用一种通用的毛细管电泳优化策略,在存在几种高甘露糖寡糖的情况下,分离单克隆抗体产品上具有功能相关性的岩藻糖基化和去岩藻糖基化聚糖。所选的 N-聚糖代表最常报道的 CHO 细胞衍生的治疗性抗体上的聚糖。通过系统评估选择性(硼酸)和效率(线性聚丙烯酰胺)增强添加剂的影响,开发了一种快速(<7 分钟)高分辨率分离 12 种常见报告和具有功能重要性的 IgG 聚糖的方法。该方法可用于快速优化其他聚糖混合物的毛细管电泳分离。优化后,该方法应用于 overnight 样品处理,用于自动化 96 孔板的两个非专利治疗性单克隆抗体的糖基化分析,证明了其坚固性和适用于高通量工艺和产品监测应用。

相似文献

3
Preparation and biological activities of anti-HER2 monoclonal antibodies with fully core-fucosylated homogeneous bi-antennary complex-type glycans.
Biosci Biotechnol Biochem. 2017 Dec;81(12):2353-2359. doi: 10.1080/09168451.2017.1394813. Epub 2017 Nov 1.
4
Generation of FX and Gmds CHOZN host cell lines for the production of afucosylated therapeutic antibodies.
Biotechnol Prog. 2021 Jan;37(1):e3061. doi: 10.1002/btpr.3061. Epub 2020 Aug 26.
5
Production, characterization, and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans.
MAbs. 2012 Jul-Aug;4(4):475-87. doi: 10.4161/mabs.20737. Epub 2012 Jul 1.
6
The Formidable Challenge of Controlling High Mannose-Type N-Glycans in Therapeutic mAbs.
Trends Biotechnol. 2020 Oct;38(10):1154-1168. doi: 10.1016/j.tibtech.2020.05.009. Epub 2020 Jun 29.

引用本文的文献

2
High-Throughput Glycomic Methods.
Chem Rev. 2022 Oct 26;122(20):15865-15913. doi: 10.1021/acs.chemrev.1c01031. Epub 2022 Jul 7.
5
Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
Toxins (Basel). 2016 Sep 12;8(9):257. doi: 10.3390/toxins8090257.
6
Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
PLoS One. 2016 Aug 25;11(8):e0161446. doi: 10.1371/journal.pone.0161446. eCollection 2016.
7
Characterization of Pharmaceutical IgG and Biosimilars Using Miniaturized Platforms and LC-MS/MS.
Curr Pharm Biotechnol. 2016;17(9):788-801. doi: 10.2174/1389201017666160401145012.
8
Structural glycomic analyses at high sensitivity: a decade of progress.
Annu Rev Anal Chem (Palo Alto Calif). 2013;6:237-65. doi: 10.1146/annurev-anchem-062012-092609. Epub 2013 Apr 3.
9
High-sensitivity analytical approaches for the structural characterization of glycoproteins.
Chem Rev. 2013 Apr 10;113(4):2668-732. doi: 10.1021/cr3003714. Epub 2013 Mar 27.
10
Evaluation of exogenous siRNA addition as a metabolic engineering tool for modifying biopharmaceuticals.
Biotechnol Prog. 2013 Mar-Apr;29(2):415-24. doi: 10.1002/btpr.1667. Epub 2013 Feb 13.

本文引用的文献

2
Biopharmaceutical benchmarks 2010.
Nat Biotechnol. 2010 Sep;28(9):917-24. doi: 10.1038/nbt0910-917.
3
Improved sample preparation method for glycan analysis of glycoproteins by CE-LIF and CE-MS.
Electrophoresis. 2010 Apr;31(8):1389-95. doi: 10.1002/elps.201000037.
5
Glycosylation as a strategy to improve antibody-based therapeutics.
Nat Rev Drug Discov. 2009 Mar;8(3):226-34. doi: 10.1038/nrd2804.
6
Monoclonal antibody "gold rush".
Curr Med Chem. 2007;14(18):1978-87. doi: 10.2174/092986707781368504.
7
Development trends for monoclonal antibody cancer therapeutics.
Nat Rev Drug Discov. 2007 May;6(5):349-56. doi: 10.1038/nrd2241.
9
The carbohydrate at FcgammaRIIIa Asn-162. An element required for high affinity binding to non-fucosylated IgG glycoforms.
J Biol Chem. 2006 Feb 24;281(8):5032-6. doi: 10.1074/jbc.M510171200. Epub 2005 Dec 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验